Skip to main content
TipRanks
Go Ultimate75% OFF

Atlas Arteria (MAQAF) AI Stock Analysis

10 Followers
MAQAF

Atlas Arteria

(Other OTC:MAQAF)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Stronger cash generationThe sharp improvement in operating and free cash flow indicates better cash conversion and greater internal funding capacity. If sustained, this supports debt servicing, distributions, and reinvestment in long-life concessions while reducing reliance on external financing.
Negative Factors
Weak underlying operating consistencyPersistent EBIT weakness and wide margin swings indicate that reported bottom-line profit does not consistently reflect stable operating earnings. This makes future cash generation and distribution capacity more dependent on non-operating items and period-specific cost outcomes.

Atlas Arteria (MAQAF) vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%MAQAF-13.88%SPY+4.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$3.78B
Dividend Yield
9.86%
Average Volume (3M)
765
Price to Earnings (P/E)
19.8
Beta (1Y)
0.17
Revenue Growth
6.68%
EPS Growth
18.69%
Country
US
Employees
50
Sector
Industrials
Sector Strength
63
Industry
Industrial - Infrastructure Operations

Atlas Arteria Business Overview & Revenue Model

Company Description

Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. Among its key holdings is a 13.4% equity stake in Toll Road Investors Partnership II (TRIP II), the concessionaire responsible for the 22-kilometer...

Atlas Arteria Earnings Call Summary

Earnings Call Date:Aug 26, 2026(Q2-2026)|% Change Since:-21.33%|Next Earnings Date:Feb 24, 2027
Earnings Call SentimentNeutral

The call presented a mixed picture. Operationally the portfolio showed resilience — underlying NPAT rose 29%, constant-currency revenue and EBITDA were marginally positive, Dulles and Chicago traffic grew, APRR issued EUR 500m of bonds, and the company maintained its $0.40 distribution guidance while strengthening liquidity. Offsetting this were sizable one-off non-operating charges (put option accounting and settlement, takeover and change-of-control costs), adverse FX translating to a ~3.9% revenue and ~3.6% EBITDA decline in AUD terms, a TRIP bond downgrade, and governance/ownership uncertainty following IFM increasing its stake to ~67%. Overall the operational positives are meaningful but balanced by significant near-term headwinds and one-off costs, leaving the tone cautiously neutral.

Positive Updates

Reaffirmed Distribution and Immediate Payout
2026 distribution guidance reaffirmed at $0.40 per security; $0.20 of that to be paid in October 2026, and management expects to continue paying the substantial majority of cash generated in line with the distribution policy (90%–110% of free cash flow).

Negative Updates

Statutory Net Loss Driven by One-Off Non-Operating Costs
Statutory net loss after tax of $73.3 million in H1 2026, driven by large non-operating items including costs related to the put option extinguishment, takeover offer expenses, and change-of-control employee costs.

Company Guidance

Management reaffirmed 2026 distribution guidance of $0.40 per security (with $0.20 to be paid in October) but said it will not provide a quantified distribution target beyond the 1‑year period, instead reverting to its distribution policy of paying 90–110% of free cash flow (while noting 2026 is expected to be above that range due to the French temporary supplemental tax and one‑offs). Key metrics cited: operating free cash flow per security was $0.191 (down 1.5% vs H1 2025); underlying NPAT was $94.3m (up 29%); on a constant‑currency basis proportional toll revenue was up 0.6% and proportional EBITDA up 0.9% (FX weakened results, leaving proportional toll revenue and EBITDA down 3.9% and 3.6% respectively); cash received from businesses was A$296m (1% lower YoY) with A$5.8m net proceeds from the FX hedge program; pro‑forma corporate cash was A$100m; APRR priced €500m of bonds in January; a new US$150m three‑year corporate facility was established to fund the US$100m put‑option settlement (the put produced an $89.1m fair‑value movement and $37.5m settlement expense), and material non‑operating charges included $24.1m of IFM takeover costs and $16.9m of change‑of‑control employee costs.

Atlas Arteria Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

MAQAF against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AU:BXBAU:BXB77OutperformAUD 29.70B20.3528.80%3.00%0.86%7.65%
AU:AZJAU:AZJ65NeutralAUD 6.56B18.428.96%5.97%5.89%21.43%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
AU:TCLAU:TCL56NeutralAUD 46.97B125.114.43%4.69%0.00%174.53%
AU:DBIAU:DBI52NeutralAUD 2.70B75.843.41%4.88%10.72%-59.88%

* Industrials Sector Average

Performance Comparison

-20%0%20%MAQAFAU:BXBAU:AZJAU:TCLAU:DBIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
MAQAF and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MAQAFAtlas Arteria2.60-0.37-12.55%
AU:BXBBrambles Limited21.83-1.04-4.53%
AU:AZJAurizon Holdings Ltd.3.850.5115.37%
AU:TCLTransurban Group Ltd.14.700.271.89%
AU:DBIDalrymple Bay Infrastructure Ltd.5.401.1627.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.